Selected Grants
SRD-001-1001
Clinical TrialPrincipal Investigator · Awarded by Sardocor Corp. · 2024 - 2032ALLAY-HF
Clinical TrialCo-Principal Investigator · Awarded by Alleviant Medical, Inc. · 2023 - 2030A Prospective, Multi-Center, Open Label, Randomized Control Clinical Trial Evaluating the Safety and Efficacy of the Cordella Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class II Heart Failure Patients (PROACTIVE-HF-2 Trial)
Clinical TrialPrincipal Investigator · Awarded by Endotronix, Inc. · 2024 - 2029Splanchnic Nerve Modulation In Heart Failure (Splanchnic X)
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2029A Phase 1b, Pilot Trial Evaluating the Safety and Pharmacodynamic Effects of SRD-001 (AAV1-SERCA2a) in Subjects with Heart Failure with Preserved Ejection Fraction
Clinical TrialPrincipal Investigator · Awarded by Sardocor Corp. · 2023 - 2028Hermes - HF
Clinical TrialPrincipal Investigator · Awarded by Novo Nordisk, Inc. · 2024 - 2028Physical Rehabilitation for Older Patients with Acute HFpEF-The REHAB-HFpEF Trial - Site Per Patient
Clinical TrialPrincipal Investigator · Awarded by Wake Forest University Health Sciences · 2023 - 2027A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction(PH-HFpEF); LEVEL:LEVosimendan to Improve Exercise Limitation in Pa
Clinical TrialPrincipal Investigator · Awarded by Tenax Therapeutics, Inc. · 2024 - 2027Fire1
Clinical TrialPrincipal Investigator · Awarded by Foundry Innovation & Research 1, Ltd. (FIRE1) · 2023 - 2027RECOVER-AUTO
Clinical TrialPrincipal Investigator · Awarded by DCRI-Duke-Site · 2023 - 2026Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Clinical TrialPrincipal Investigator · Awarded by Procyrion, Inc. · 2023 - 2026Pulmonary Artery DenerVation Clinical Study using the Gradient Denervation System in Heart Failure Patients with Pulmonary Hypertension Group 2 (PreVail-PH2 Study)
Clinical TrialPrincipal Investigator · Awarded by Gradient Denervation Technologies · 2024 - 2026Prediction and Prevention of Hepatic Decompensation in Patients with Cirrhosis
Clinical TrialCollaborator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2021 - 2026Transforming Urine Output Tracking in Hospitalized Heart Failure Patients
ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2026Poseidon
ResearchPrincipal Investigator · Awarded by Novo Nordisk A/S · 2024 - 2025Physical Rehabilitation for Older Patients with Acute HFpEF-The REHAB-HFpEF Trial - Site Administration
Clinical TrialPrincipal Investigator · Awarded by Wake Forest University Health Sciences · 2023 - 2025Role of the Splanchnic Vascular Compartment in Heart Failure with Preserved Ejection Fraction
ResearchPrincipal Investigator · Awarded by Doris Duke Charitable Foundation, Inc. · 2022 - 20251/2 Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction Extension Trial
ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2025Fluid management of Acute decompensated heart failure subjects treated with reprieve decongestion management system (DMS) - FASTR Trial
Clinical TrialPrincipal Investigator · Awarded by Reprieve Cardiovascular, Inc. · 2023 - 2025IMAGING CORE LABORATORY: HEMODYNAMICS CORE FOR ACORAI MLG
ResearchPrincipal Investigator · Awarded by Acorai AB · 2023 - 2024Center for Advancing Point of Care Technologies (CAPCaT) in HLBS Disorders.
ResearchPrincipal Investigator · Awarded by Daxor Corporation · 2024 - 2024Hemodynamics Core Study
ResearchPrincipal Investigator · Awarded by Cardiosense, Inc. · 2023 - 2024Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having Heart Failure with Preserved Ejection Fraction: Randomized Controlled Feasibility Trial
Clinical TrialPrincipal Investigator · Awarded by Axon Therapies, Inc. · 2024 - 2024An acute porcine model for Cardiac-Synchronized Diaphragmatic Stimulation as a novel extra-cardiac intervention for symptomatic chronic heart failure
ResearchCollaborator · Awarded by VisCardia, Inc. · 2022 - 2024CONFIDENT-HFpEF Phase 1
ResearchPrincipal Investigator · Awarded by Owkin, Inc. · 2023 - 2023SOLENOID PHASE 1
ResearchPrincipal Investigator · Awarded by Owkin, Inc. · 2023 - 2023Cardiac Filling Pressure Estimation with a Non-Invasive Device (Pufferfish)
Clinical TrialPrincipal Investigator · Awarded by Verily Life Sciences, LLC · 2022 - 2023Is Heart Failure with Preserved Edection Fraction the Symptomatic Manifestation of Liver Disease
ResearchPrincipal Investigator · Awarded by American Heart Association · 2021 - 2022Digoxin Toxicity Study
Clinical TrialPrincipal Investigator · Awarded by BTG International Inc · 2021 - 2022Congestion Phenotypes and Splanchnic Nerve Modulation in Chronic Heart Failure
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2022Splanchnic Nerve Block for Therapy of Acute Heart Failure (Splanchnic HF)
Clinical TrialPrincipal Investigator · Awarded by American Heart Association · 2017 - 2019External Relationships
- ADI
- Abbott Laboratories
- Acorai
- Ajax
- Akros
- Alio
- Alleviant Medical
- Artha
- Astellas Pharma Inc.
- Audicor
- Axon Therapies
- Bodiguide
- Bodyport
- Boston Scientific Corporation
- Broadview Ventures
- CVRx
- Cadence
- Cardioflow
- Cardiosense, Inc
- Clinical accelerator
- Daxor
- EKO Inc
- Echosens
- Endotronix
- Feldschuh Foundation
- Fire1
- FutureCardia
- Gradient
- Hatteras Investment Partners, LLC
- Heka Heart
- HemodynamIQ
- ISHI
- Impulse Dynamics
- Intershunt
- Lexicon Pharmaceuticals, Inc.
- Maxwell Biomedical
- Medtronic
- Merck
- Ni-Medical
- Novo Nordisk
- Nucleus Rx
- Orchestra
- Paragate
- Parasym
- Pharmacosmos
- PreHealth
- Presidio Medical
- Procyreon
- Proton Intelligence
- Puzzle Medical
- ReCor
- Respicardia
- Restore Medical
- SC Pharma
- Scirent
- Shifamed
- Splendo Health Duke startup
- Summacor
- SyMap
- Vascular Dynamics
- Verily LIfe Sciences
- Vironix
- Viscardia
- Zoll
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.